PRENW Prenetics Global Ltd

NEUTRAL Impact: 3/10 6-K
Horizon weeks Filed May 14, 2026 Processed 26d 18h ago SEC 0001628280-26-034812
Notable filing: 6-K
Latest settled — T+5d ⚠ clustered
PRENW ▲ 0.00% at T+5d
NEUTRAL call ✗ call lost 0.00% · α vs SPY +0.72% · entry $0.0195 → $0.0195
Next anchor: T+20d in 2d
Currently $0.0195 · +0.00% from $0.0195 entry
Entry anchored
May 12, 03:29 PM ET
via Databento tick
T+1d
0.00%
call 0.00% · α +1.23%
$0.0195
settled 26d ago
T+5d
0.00%
call 0.00% · α +0.72%
$0.0195
settled 20d ago
T+20d
call — · α —
in 2d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Prenetics Global Ltd announced the appointment of Brian J. Rosin as CFO of its IM8 subsidiary, a premium health and longevity brand co-founded with David Beckham. The press release includes a forward-looking revenue projection of $190M-$210M for IM8 in FY2026, its second year from launch, and notes the brand surpassed $100M in annualized recurring revenue within 11 months. This is a routine executive appointment with no immediate financial impact on the company's consolidated results.

Actionable Insight

This is a routine executive hire with no material change to the company's financials or outlook. Monitor upcoming quarterly filings for actual IM8 revenue performance against the $190M-$210M projection.

Key Facts

  • Brian J. Rosin appointed CFO of IM8, effective May 14, 2026
  • IM8 projects $190M to $210M in revenue for full year 2026
  • IM8 surpassed $100M in annualized recurring revenue within 11 months of launch
  • IM8 is sold in more than 40 countries
  • Mr. Rosin brings nearly two decades of financial leadership in consumer e-commerce and premium wellness brands

Financial Impact

No immediate financial impact; IM8 revenue projection of $190M-$210M for FY2026 is forward-looking and not a hard guidance

revenue

Risk Factors

  • Forward-looking revenue projections may not materialize due to competition, supply chain, or brand execution risks
  • IM8's rapid growth may pressure margins and require additional capital

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001628280-26-034812
Document: im8cfoannouncement140526_f.htm0001628280-26-034812
Document: 0001628280-26-034812-index-headers.html0001628280-26-034812
Document: 0001628280-26-034812-index.html0001628280-26-034812
Document: 0001628280-26-034812.txt0001628280-26-034812
6 reports for PRENW
Performance horizon
0% Hit rate 0 of 5 directional calls best @ T+1· 0.00%Apr 2, 2026
Filters
Rows
Reports for PRENW — sortable, filterable
Type Now
Jun 4, 2026
5d ago
6-K
BULLISH ★ 5/10
$0.0195 $0.0195· 0.00%▲ +2.60%$0.0195 (+0.00%)
May 20, 2026
20d ago
6-K
BULLISH ★ 6/10
$0.0195 $0.0195· 0.00%▼ −0.19%$0.0195 (+0.00%)
May 14, 2026
26d ago
6-K
NEUTRAL ★ 3/10
$0.0195 $0.0195· 0.00%▲ +1.23%$0.0195 (+0.00%)
May 14, 2026
26d ago
6-K
BULLISH ★ 7/10
$0.0195 $0.0195· 0.00%▲ +1.23%$0.0195 (+0.00%)
May 4, 2026
5w ago
6-K
BULLISH ★ 6/10
$0.0195 $0.0195· 0.00%▼ −0.80%$0.0195 (+0.00%)
Apr 2, 2026
9w ago
6-K
BULLISH ★ 7/10
$0.0195 $0.0195· 0.00%▼ −0.48%$0.0195 (+0.00%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 7h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access